Please access the EAACI Committee's terms of reference here.
Antonella Muraro & Graham RobertsLast updated: 22 May 2019
Please access the status report of the EAACI Guidelines Committee here.Last updated: 21 May 2019
This is based on the authorship policy used for the EAACI Allergen Immunotherapy Guidelines.
1. The authorship policy is based on the recommendations from the International Committee of Medical Journal Editors. Authorship is based on meeting all of conditions i, ii, and iii:
i. substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data;
ii. drafting the article or revising it critically for important intellectual content;
iii. final approval of the version to be published.
2. Authorship is dependent on approval of the publication within 14 day timescale from the final draft being circulated. Failure to respond will result in non-inclusion as an author.
3. Collaborators who meet less than 3 of the criteria will be mentioned in the acknowledgement section at the base of the manuscript. This will allow them to be cited in online databases of scientific literature.
4. All publications will include the wording ‘On behalf of EAACI XXXXXX Guidelines Group’.
5. The first and second authors of guidelines will be expected to be the Chair and Secretary of the guideline Taskforce respectively; where there is a collection of Taskforces generating interconnecting guidelines with one project chair, the last author would be expected to be the project chair.
6. Guideline Committee members will only be expected to be authors for specific guidelines if they have made a significant contribution to the guideline as described above.
7. Guidelines will be expected to acknowledge the support of the EAACI Guidelines Committee naming the current members of the Committee.Last updated: 22 May 2019
The approach to developing EAACI guidelines has developed over the last decade. The current approach was developed for the EAACI Allergen Immunotherapy Guidelines project.
Developing proposals for new guidelines
· A call to EAACI members for suggestions for new guidelines and revisions of previous guidelines will be circulated in the spring.
· Proposed new guidelines and revisions of previous guidelines will be reviewed at the annual Committee face to face meeting. They will be prioritised on the basis of:
- Importance for patients – focus on areas where there is an important gap in disease management and resulting negative impact on patients
- Strategic importance for EAACI – to facilitate dissemination and implementation, potential new guidelines should be aligned with other EAACI activities
- Applicability – allergic disease, asthma or immunology orientated topic area
- Feasibility – sufficient evidence and members with expertise to generate evidence based guideline; the area should not be so large to make generating a guideline would be impossible
· On the basis of the Committee discussions, a proposal for new guidelines and revision of previous guidelines will be drafted by the Chair and Secretary for submission to the autumn Executive Committee meeting.
Approving new guidelines Taskforces
· The Committee Chair will propose potential new guidelines to the Executive Committee in the Autumn
· The Executive Committee will approve new guidelines on the basis of their, importance for patients, strategic importance for EAACI, applicability, feasibility and detailed business plan
Guideline development process
· An evidence based approach to guideline development will be used utilising an established process such as Agree II
· A systematic search for evidence related to the guideline area will be made
· Evidence will be appraised using a recognised approach
· Evidence will be synthesised, using systematic review and meta-analysis where appropriate
· Evidence based recommendations will be developed; where evidence is not available, recommendations will be based on consensus
· The final draft guidelines will be reviewed by external experts, EAACI members and public via EAACI website with revisions being made as necessary and appropriate
Approving final guideline documents
· Prior to submission for publication, the guideline will be sent to the Executive Committee for review and comment. In line with international guideline recommendations, it is expected that the views or interests of the funding body will not influence the final recommendations explaining why guidelines are not approved by the Executive Committee as per position papers.
Publication of guideline
Protocols for systematic reviews, systematic reviews and the guidelines are expected to be published in EAACI official journals. Publication should be within a reasonable timeframe given how rapidly these documents can become outdated.Last updated: 22 May 2019